| pubmed-article:1594216 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1594216 | lifeskim:mentions | umls-concept:C0015677 | lld:lifeskim |
| pubmed-article:1594216 | lifeskim:mentions | umls-concept:C0029130 | lld:lifeskim |
| pubmed-article:1594216 | lifeskim:mentions | umls-concept:C0011304 | lld:lifeskim |
| pubmed-article:1594216 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:1594216 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:1594216 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
| pubmed-article:1594216 | lifeskim:mentions | umls-concept:C1627358 | lld:lifeskim |
| pubmed-article:1594216 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:1594216 | pubmed:dateCreated | 1992-7-2 | lld:pubmed |
| pubmed-article:1594216 | pubmed:abstractText | Conventional spin-echo magnetic resonance imaging (MRI) of intraorbital optic neuritis is hampered by the adjacent high signal and chemical shift artifact of orbital fat. Frequency-selective saturation pulse MRI reduces these problems and was used to determine its utility in evaluation of intraorbital optic neuritis. Eight consecutive patients with optic neuritis underwent MRI within 1 week of the onset of visual loss. Conventional MRI with T1, proton density, and T2 weighting and frequency-selective saturation pulse MRI with T1, proton density, and T2 weighting were performed. After administration of intravenous gadopentetate dimeglumine, T1-weighted conventional and frequency-selective saturation pulse MRI were performed. Frequency-selective saturation pulse MRI showed gadopentetate dimeglumine enhancement in the intraorbital optic nerve in 7 patients and the intracranial optic nerve in 3 patients. Conventional MRI failed to show optic nerve gadopentetate dimeglumine enhancement in patients with intraorbital lesions, but did show intracranial lesions. Frequency-selective saturation pulse MRI showed bilateral optic nerve enhancement in 3 patients with unilateral visual signs and symptoms. Proton density and T2-weighted conventional MRI of the brain showed no convincing signal aberrations in the optic nerves. In the MRI evaluation of intraorbital optic neuritis: (1) frequency-selective saturation pulse fat suppression MRI is superior to T1-weighted conventional MRI in the detection of gadopentetate dimeglumine enhancement; (2) frequency-selective saturation pulse proton density and T2-weighted MRI is superior to proton density and T2-weighted conventional MRI; (3) frequency-selective saturation pulse MRI showed gadopentetate dimeglumine enhancement as well as proton density/T2-weighted signal aberration in exactly the same portion of the intraorbital optic nerve. | lld:pubmed |
| pubmed-article:1594216 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1594216 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1594216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1594216 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1594216 | pubmed:month | May | lld:pubmed |
| pubmed-article:1594216 | pubmed:issn | 0161-6420 | lld:pubmed |
| pubmed-article:1594216 | pubmed:author | pubmed-author:GuyJJ | lld:pubmed |
| pubmed-article:1594216 | pubmed:author | pubmed-author:MancusoAA | lld:pubmed |
| pubmed-article:1594216 | pubmed:author | pubmed-author:MajGG | lld:pubmed |
| pubmed-article:1594216 | pubmed:author | pubmed-author:QuislingR GRG | lld:pubmed |
| pubmed-article:1594216 | pubmed:author | pubmed-author:BidgoodW... | lld:pubmed |
| pubmed-article:1594216 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1594216 | pubmed:volume | 99 | lld:pubmed |
| pubmed-article:1594216 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1594216 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1594216 | pubmed:pagination | 713-9 | lld:pubmed |
| pubmed-article:1594216 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:meshHeading | pubmed-meshheading:1594216-... | lld:pubmed |
| pubmed-article:1594216 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1594216 | pubmed:articleTitle | Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging. | lld:pubmed |
| pubmed-article:1594216 | pubmed:affiliation | Department of Ophthalmology, University of Florida, Gainesville 32610-0284. | lld:pubmed |
| pubmed-article:1594216 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1594216 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:1594216 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1594216 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1594216 | lld:pubmed |
